Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 23/Signature 1

EditHistoryDelete

Mark reviewed

Your review change was submitted

Needs review

Curated date: 2024/11/10

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 11: Figure S11

Description: Differentially abundant taxa between the Naive group and HRZ (H-Isoniazid, R-Rifampin, Z-Pyrazinamide) treatment group.

Abundance in Group 1: increased abundance in HRZ(H-Isoniazid, R-Rifampin, Z-Pyrazinamide)

NCBI	Quality Control	Links
Anaeroplasma
Anaerostipes
Anaerovorax
Asaccharobacter
Barnesiella
Butyricicoccus
Erysipelothrix
Eubacteriales Family XIII. Incertae Sedis
Mucispirillum
Parabacteroides
Thomasclavelia

Revision editor(s): KateRasheed